Ernexa Therapeutics Inc. (ERNA) has a market capitalization of $1.49M and trades at $0.19. The 52-week range is 0.18-4.05.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-2.24.
The stock has a beta of 6.85, operates in the Healthcare sector.
